명태(Theragra chalcogramma) 껍질 유래 젤라틴 가수분해물의 항 HIV-1 효능
Anti-HIV-1 Activity of Gelatin Hydrolysate Derived from Alaska Pollack Theragra chalcogramma Skin
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Infection with HIV [Human immunodeficiency virus], over time, develops into acquired immunodeficiency syndrome (AIDS). The development of non-toxic and effective anti-HIV drugs is one of the most promising strategies for the treatment of AIDS. In this study, we investigated the anti-HIV-1 activity of gelatin hydrolysates from Alaska pollack skin. Gelatin hydrolysates were prepared using four enzymes (alcalase, flavourzyme, neutrase, and pronase E). Among these, the pronase E gelatin hydrolysate was found to inhibit HIV-1 infection in the human T cell-line MT4. It exhibited inhibitory activity on HIV-1IIIB-induced cell lysis, reverse transcriptase activity, and viral p24 production at noncytotoxic concentrations. Moreover, it decreased the activation of matrix metalloproteinase-2 (MMP-2) in vitro. Because HIV infection-induced activation of MMP-2 can accelerate collagen resolution and collapse of the immune system, pronase E gelatin hydrolysate might prevent the activation of MMP-2 in cells, resulting in collagen stabilization and immune cell homeostasis consistent with anti-HIV activation. These results suggest that pronase E gelatin hydrolysate could potentially be incorporated into a novel therapeutic agent for HIV/AIDS patients.
Abstract
Infection with HIV [Human immunodeficiency virus], over time, develops into acquired immunodeficiency syndrome (AIDS). The development of non-toxic and effective anti-HIV drugs is one of the most promising strategies for the treatment of AIDS. In this study, we investigated the anti-HIV-1 activity of gelatin hydrolysates from Alaska pollack skin. Gelatin hydrolysates were prepared using four enzymes (alcalase, flavourzyme, neutrase, and pronase E). Among these, the pronase E gelatin hydrolysate was found to inhibit HIV-1 infection in the human T cell-line MT4. It exhibited inhibitory activity on HIV-1IIIB-induced cell lysis, reverse transcriptase activity, and viral p24 production at noncytotoxic concentrations. Moreover, it decreased the activation of matrix metalloproteinase-2 (MMP-2) in vitro. Because HIV infection-induced activation of MMP-2 can accelerate collagen resolution and collapse of the immune system, pronase E gelatin hydrolysate might prevent the activation of MMP-2 in cells, resulting in collagen stabilization and immune cell homeostasis consistent with anti-HIV activation. These results suggest that pronase E gelatin hydrolysate could potentially be incorporated into a novel therapeutic agent for HIV/AIDS patients.
참고문헌 (14)
- 안용석, "옥돔(Branchiostegus japonicus) 비늘 유래 젤라틴의 가수분해 및 가수분해물의 기능성", 한국수산과학회지, 42(5), pp.417~425 (2009), 한국수산과학회
- F Barre-Sinoussi, "Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)", Science, 220(4599), pp.868~871 (1983), American Association for the Advancement of Science (AAAS)[DOI]
- Karen Anderson, "Developing Novel Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors: Beyond the Butterfly", Current Pharmaceutical Design, 12(15), pp.1857~1865 (2006), Bentham Science Publishers Ltd.[DOI]
- Alba Diaz, "Factors associated with collagen deposition in lymphoid tissue in long-term treated HIV-infected patients", AIDS, 24(13), pp.2029~2039 (2010), Ovid Technologies (Wolters Kluwer Health)[DOI]
- Jacob D. Estes, "The role of collagen deposition in depleting CD4+ T cells and limiting reconstitution in HIV-1 and SIV infections through damage to the secondary lymphoid organ niche", Seminars in Immunology, 20(3), pp.181~186 (2008), Elsevier BV[DOI]
- R. Gallo, "Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS)", Science, 220(4599), pp.865~867 (1983), American Association for the Advancement of Science (AAAS)[DOI]
- 허민수, "명태 수리미 부산물 유래 젤라틴 가수분해물을 이용한 시판 간장의 항산화성 및 ACE 저해활성의 개선", 한국수산과학회지, 43(3), pp.179~187 (2010), 한국수산과학회
- Susan Kasedde, "Executive Summary", JAIDS Journal of Acquired Immune Deficiency Syndromes, 66, pp.S139~S143 (2014), Ovid Technologies (Wolters Kluwer Health)[DOI]
- Rebecca L Kusko, "Premature expression of a muscle fibrosis axis in chronic HIV infection", Skeletal Muscle, 2(1), pp.10~ (2012), Springer Nature[DOI]
- Claudio M. Mastroianni, "Matrix metalloproteinase dysregulation in HIV infection: implications for therapeutic strategies", Trends in Molecular Medicine, 13(11), pp.449~459 (2007), Elsevier BV[DOI]
- Alberto Plaza, "Celebesides A−C and Theopapuamides B−D, Depsipeptides from an Indonesian Sponge That Inhibit HIV-1 Entry", The Journal of Organic Chemistry, 74(2), pp.504~512 (2009), American Chemical Society (ACS)[DOI]
- Martin Ruehl, "Hydroxyproline-containing collagen analogs trigger the release and activation of collagen-sequestered proMMP-2 by competition with prodomain-derived peptide P33-42", Fibrogenesis & Tissue Repair, 4(1), pp.33~42 (2011), Springer Nature[DOI]
- Angela Zampella, "Homophymine A, an anti-HIV cyclodepsipeptide from the sponge Homophymia sp", The Journal of Organic Chemistry, 73(14), pp.5319~5327 (2008), American Chemical Society (ACS)[DOI]